Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (131-140 of 387) with videos related to

Pageof 39
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 28, 2004
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 13, 2006
Natural history of thromboembolism in AL amyloidosisChristine S Halligan, Martha Q Lacy, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphomaThomas E Witzig, Ian W Flinn, Leo I Gordon, et al.
Blood|November 24, 2005
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemiaSherine F Elsawa, Anne J Novak, Deanna M Grote, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Blood|October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytomaShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Clinical Pharmacokinetics|January 28, 2026
Use of a Cystatin C-Based GFR Equation in a Population Pharmacokinetic Model of Methotrexate Clearance in Adult Patients with LymphomaZachary L Taylor, Erin F Barreto, Kristin C Cole, et al.
Plos One|April 5, 2013
Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphomaZhi-Zhang Yang, Deanna M Grote, Steven C Ziesmer, et al.
Leukemia & Lymphoma|December 3, 2005
A phase II trial of imatinib in patients with refractory/relapsed myelomaAngela Dispenzieri, Morie A Gertz, Martha Q Lacy, et al.
Pageof 39

Showing results (131-140 of 387) with videos related to

Sort By:
Pageof 39
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 28, 2004
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 13, 2006
Natural history of thromboembolism in AL amyloidosisChristine S Halligan, Martha Q Lacy, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphomaThomas E Witzig, Ian W Flinn, Leo I Gordon, et al.
Blood|November 24, 2005
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemiaSherine F Elsawa, Anne J Novak, Deanna M Grote, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Blood|October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytomaShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Clinical Pharmacokinetics|January 28, 2026
Use of a Cystatin C-Based GFR Equation in a Population Pharmacokinetic Model of Methotrexate Clearance in Adult Patients with LymphomaZachary L Taylor, Erin F Barreto, Kristin C Cole, et al.
Plos One|April 5, 2013
Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphomaZhi-Zhang Yang, Deanna M Grote, Steven C Ziesmer, et al.
Leukemia & Lymphoma|December 3, 2005
A phase II trial of imatinib in patients with refractory/relapsed myelomaAngela Dispenzieri, Morie A Gertz, Martha Q Lacy, et al.
Pageof 39